The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes (Q84806554)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22895807%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22895807%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

M Lind

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22895807%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

M Olsson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22895807%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

A Rosengren

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22895807%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

A-M Svensson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22895807%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

I Bounias

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22895807%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

S Gudbjörnsdottir

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22895807%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

16 August 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22895807%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22895807%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22895807%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22895807%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

2946-2953

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22895807%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00125-012-2681-3

11 February 2020

exact match

0 references

cites work

Mortality in people with Type 2 diabetes in the UK

1 reference

12 December 2020

The true value of HbA1c as a predictor of diabetic complications: simulations of HbA1c variables.

1 reference

12 December 2020

The validity of a diagnosis of heart failure in a hospital discharge register

1 reference

12 December 2020

Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study

1 reference

12 December 2020

Glycemic control and heart failure among adult patients with diabetes

1 reference

12 December 2020

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

1 reference

12 December 2020

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Card

1 reference

12 December 2020

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Effects of intensive glucose lowering in type 2 diabetes

1 reference

12 December 2020

Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes

1 reference

12 December 2020

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

1 reference

12 December 2020

The health care costs of heart failure in Sweden.

1 reference

12 December 2020

The incidence of congestive heart failure in type 2 diabetes: an update

1 reference

12 December 2020

Intensive glucose control and macrovascular outcomes in type 2 diabetes.

1 reference

12 December 2020

Survival trends in men and women with heart failure of ischaemic and non-ischaemic origin: data for the period 1987-2003 from the Swedish Hospital Discharge Registry

1 reference

12 December 2020

Diabetes mellitus, fasting glucose, and risk of cause-specific death

1 reference

12 December 2020

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

12 December 2020

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

12 December 2020

IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study.

1 reference

12 December 2020

10-year follow-up of intensive glucose control in type 2 diabetes

1 reference

12 December 2020

New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR)

1 reference

12 December 2020

Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study

1 reference

12 December 2020

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

12 December 2020

Effects of intensive glucose lowering in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial

1 reference

12 December 2020